Relationship between quality of life indicators and cardiac status indicators in chemotherapy patients

1Strongman H, Gadd S, Matthews A, Mansfield KE, Stanway S, Lyon AR, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked uk electronic health records databases. Lancet. 2019;394(10203):1041-54. doi: 10.1016/S0140-6736(19)31674-5. Strongman H Gadd S Matthews A Mansfield KE Stanway S Lyon AR et al Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked uk electronic health records databases Lancet 2019394102031041 54 10.1016/S0140-6736(19)31674-5Open DOISearch in Google Scholar

2Coviello JS. Cardiovascular and cancer risk: the role of cardio-oncology. J Adv Pract Oncol. 2018;9(2):160-76. doi: 10.6004/jadpro.2018.9.2. Coviello JS Cardiovascular and cancer risk: the role of cardio-oncology J Adv Pract Oncol 201892160 76 10.6004/jadpro.2018.9.2Open DOISearch in Google Scholar

3Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M, et al. The growing role of precision and personalized medicine for cancer treatment. Technology (Singap World Sci). 2018;6(3-4):79-100. doi: 10.1142/S2339547818300020. Krzyszczyk P Acevedo A Davidoff EJ Timmins LM Marrero-Berrios I Patel M et al The growing role of precision and personalized medicine for cancer treatment Technology (Singap World Sci) 201863-479 100 10.1142/S2339547818300020635231230713991Open DOISearch in Google Scholar

4Page RL 2nd, O’Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, et al. Drugs that may cause or exacerbate heart failure: a scientific statement from the american heart association. 2016;134(12):e261. Circulation. 2016;134(6):e32-69. doi: 10.1161/CIR.0000000000000426. Page RL O’Bryant CL Cheng D Dow TJ Ky B Stein CM et al Drugs that may cause or exacerbate heart failure: a scientific statement from the american heart association 201613412e261 Circulation. 2016;134(6):e32-69 10.1161/CIR.000000000000042627400984Open DOISearch in Google Scholar

5Marinko T, Dolenc J, Bilban-Jakopin C. Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer. Radiol Oncol. 2014;48(2):105-12. doi: 10.2478/raon-2013-0040. Marinko T Dolenc J Bilban-Jakopin C Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer Radiol Oncol 2014482105 12 10.2478/raon-2013-0040407802824991199Open DOISearch in Google Scholar

6Alvarez JA, Russell RR. Cardio-oncology: the nuclear option. Curr Cardiol Rep. 2017;19(4):31. doi: 10.1007/s11886-017-0844-z. Alvarez JA Russell RR Cardio-oncology: the nuclear option Curr Cardiol Rep 201719431 10.1007/s11886-017-0844-z28315122Open DOISearch in Google Scholar

7Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire c30. J Clin Oncol. 2004;22(17):3485-90. doi: 10.1200/JCO.2004.03.025. Fromme EK Eilers KM Mori M Hsieh YC Beer TM How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire c30 J Clin Oncol 200422173485 90 10.1200/JCO.2004.03.02515337796Open DOISearch in Google Scholar

8Grašič Kuhar C, Gortnar Cepeda T, Kovač T, Kukar M, Ružić Gorenjec N. Mobile app for symptom management and associated quality of life during systemic treatment in early stage breast cancer: nonrandomized controlled prospective cohort study. JMIR Mhealth Uhealth. 2020;8(8):e17408. doi: 10.2196/17408. Grašič Kuhar C Gortnar Cepeda T Kovač T Kukar M Ružić Gorenjec N Mobile app for symptom management and associated quality of life during systemic treatment in early stage breast cancer: nonrandomized controlled prospective cohort study JMIR Mhealth Uhealth 202088e17408 10.2196/17408743568132427567Open DOISearch in Google Scholar

9Drafts BC, Twomley KM, D’Agostino R Jr, Lawrence J, Avis N, Ellis LR, et al. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imaging. 2013;6(8):877-85. doi: 10.1016/j.jcmg.2012.11.017. Drafts BC Twomley KM D’Agostino R Jr Lawrence J Avis N Ellis LR et al Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease JACC Cardiovasc Imaging 201368877 85 10.1016/j.jcmg.2012.11.017374580123643285Open DOISearch in Google Scholar

10Giusca S, Korosoglou G, Montenbruck M, Geršak B, Schwarz AK, Esch S, et al. Multiparametric early detection and prediction of cardiotoxicity using myocardial strain, t1 and t2 mapping and biochemical markers: a longitudinal cardiac resonance imaging study during two years of follow-up. Circ Cardiovasc Imaging. 2021;14:e012459. doi: 10.1161/ CIRCIMAGING.121.012459. Giusca S Korosoglou G Montenbruck M Geršak B Schwarz AK Esch S et al Multiparametric early detection and prediction of cardiotoxicity using myocardial strain, t1 and t2 mapping and biochemical markers: a longitudinal cardiac resonance imaging study during two years of follow-up Circ Cardiovasc Imaging 202114e012459 10.1161/CIRCIMAGING.121.012459820809234126756Open DOISearch in Google Scholar

11Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: esmo clinical practice guidelines. Ann Oncol. 2012;23(Suppl 7):vii155-66. doi: 10.1093/annonc/mds293. Curigliano G Cardinale D Suter T Plataniotis G de Azambuja E Sandri MT et al Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: esmo clinical practice guidelines Ann Oncol 201223Suppl 7vii155 66 10.1093/annonc/mds29322997448Open DOISearch in Google Scholar

12Balestroni G, Bertolotti G. EuroQol-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Arch Chest Dis. 2012;78(3):155-9. doi: 10.4081/monaldi.2012.121. Balestroni G Bertolotti G EuroQol-5D (EQ-5D): an instrument for measuring quality of life Monaldi Arch Chest Dis 2012783155 9 10.4081/monaldi.2012.12123614330Open DOISearch in Google Scholar

13Eq-5d-5l user guide: basic information on how to use the eq-5d-5l instrument. Accessed March 30th, 2021 at: https://euroqol.org/wp-content/uploads/2019/09/EQ-5D-5L-English-User-Guide_version-3.0-Sept-2019-secured.pdf Eq-5d-5l user guide: basic information on how to use the eq-5d-5l instrument. Accessed March 30th 2021 https://euroqol.org/wp-content/uploads/2019/09/EQ-5D-5L-English-User-Guide_version-3.0-Sept-2019-secured.pdfSearch in Google Scholar

14Eq-5d (euroqol) • definition | gabler wirtschaftslexikon. Accessed February 27th, 2021 at: https://wirtschaftslexikon.gabler.de/definition/eq-5d-euroqol-51755 Eq-5d (euroqol) • definition | gabler wirtschaftslexikon. Accessed February 27th 2021 https://wirtschaftslexikon.gabler.de/definition/eq-5d-euroqol-51755Search in Google Scholar

15Hinz A, Kohlmann T, Stöbel-Richter Y, Zenger M, Brähler E. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Qual Life Res. 2014;23(2):443-7. doi: 10.1007/s11136-013-0498-2. Hinz A Kohlmann T Stöbel-Richter Y Zenger M Brähler E The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population Qual Life Res 2014232443 7 10.1007/s11136-013-0498-223921597Open DOISearch in Google Scholar

16SF-36 Health survey: manual & interpretation guide. Accessed March 30th, 2021 at: https://www.researchgate.net/publication/313050850_SF-36_Health_Survey_Manual_Interpretation_Guide SF-36 Health survey: manual & interpretation guide Accessed March 30th 2021 https://www.researchgate.net/publication/313050850_SF-36_Health_Survey_Manual_Interpretation_GuideSearch in Google Scholar

17Sf-36 | springerlink. Accessed March 30th, 2021 at: https://link.springer.com/referenceworkentry/10.1007%2F978-1-4419-1005-9_1597 Sf-36 | springerlink. Accessed March 30th 2021 https://link.springer.com/referenceworkentry/10.1007%2F978-1-4419-1005-9_1597Search in Google Scholar

18Ellert U, Bellach BM. Der sf-36 im bundes-gesundheitssurvey - beschreibung einer aktuellen normstichprobe. Gesundheitswesen. 1999;61:S184-90. Ellert U Bellach BM Der sf-36 im bundes-gesundheitssurvey - beschreibung einer aktuellen normstichprobe Gesundheitswesen 199961S184 90Search in Google Scholar

19Koos R, Altiok E, Doetsch J, Neizel M, Krombach G, Marx N, et al. Layer-specific strain-encoded mri for the evaluation of left ventricular function and infarct transmurality in patients with chronic coronary artery disease. Int J Cardiol. 2013;166(1):85-9. doi: 10.1016/j. ijcard.2011.10.004. Koos R Altiok E Doetsch J Neizel M Krombach G Marx N et al Layer-specific strain-encoded mri for the evaluation of left ventricular function and infarct transmurality in patients with chronic coronary artery disease Int J Cardiol 2013166185 9 10.1016/j.ijcard.2011.10.00422071039Open DOISearch in Google Scholar

20Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and The European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15(10):1063-93. doi: 10.1093/ehjci/jeu192. Plana JC Galderisi M Barac A Ewer MS Ky B Scherrer-Crosbie M et al Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and The European Association of Cardiovascular Imaging Eur Heart J Cardiovasc Imaging 201415101063 93 10.1093/ehjci/jeu192440236625239940Open DOISearch in Google Scholar

21Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 esc position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the esc committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (esc). Eur Heart J. 2016;37(36):2768-801. doi: 10.1093/ eurheartj/ehw211. Zamorano JL Lancellotti P Rodriguez Muñoz D Aboyans V Asteggiano R Galderisi M et al 2016 esc position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the esc committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (esc) Eur Heart J 201637362768 801 10.1093/eurheartj/ehw21127567406Open DOISearch in Google Scholar

22Petek D, Petek-Ster M, Tusek-Bunc K. Health behavior and health-related quality of life in patients with a high risk of cardiovascular disease. Zdr Varst. 2018;57(1):39-46. doi: 10.2478/sjph-2018-0006. Petek D Petek-Ster M Tusek-Bunc K Health behavior and health-related quality of life in patients with a high risk of cardiovascular disease Zdr Varst 201857139 46 10.2478/sjph-2018-0006589436829651314Open DOISearch in Google Scholar

23Prevolnik Rupel V, Ogorevc M, IMPACT HTA HRQoL Group. EQ-5D-Y value set for Slovenia. Pharmacoeconomics. 2021;39(4):463-71. doi: 10.1007/s40273-020-00994-4. Prevolnik Rupel V Ogorevc M IMPACT HTA HRQoL Group. EQ-5D-Y value set for Slovenia Pharmacoeconomics 2021394463 71 10.1007/s40273-020-00994-4800980033565048Open DOISearch in Google Scholar

24Prevolnik Rupel V, Srakar A, Rand K. Valuation of EQ-5D-3l health states in Slovenia: VAS based and TTO based value sets. Zdr Varst. 2020;59(1):8-17. doi: 10.2478/sjph-2020-0002. Prevolnik Rupel V Srakar A Rand K Valuation of EQ-5D-3l health states in Slovenia: VAS based and TTO based value sets Zdr Varst 20205918 17 10.2478/sjph-2020-0002747808432952698Open DOISearch in Google Scholar

25Schneider JE, Stojanovic I. Economic evaluation of cardiac magnetic resonance with fast-senc in the diagnosis and management of early heart failure. Health Econ Rev. 2019;9(1):13. doi: 10.1186/s13561-019-0229-7. Schneider JE Stojanovic I Economic evaluation of cardiac magnetic resonance with fast-senc in the diagnosis and management of early heart failure Health Econ Rev 20199113 10.1186/s13561-019-0229-7673430031123926Open DOISearch in Google Scholar

26Thavendiranathan P, Wintersperger BJ, Flamm SD, Marwick TH. Cardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy: a systematic review. Circ Cardiovasc Imaging. 2013;6(6):1080-91. doi: 10.1161/CIRCIMAGING.113.000899. Thavendiranathan P Wintersperger BJ Flamm SD Marwick TH Cardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy: a systematic review Circ Cardiovasc Imaging 2013661080 91 10.1161/CIRCIMAGING.113.00089924254478Open DOISearch in Google Scholar